148 related articles for article (PubMed ID: 377915)
21. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
[TBL] [Abstract][Full Text] [Related]
22. Roentgen appearance of bone and soft tissue changes in chronic renal disease.
Greenfield GB
Am J Roentgenol Radium Ther Nucl Med; 1972 Dec; 116(4):749-57. PubMed ID: 4566090
[No Abstract] [Full Text] [Related]
23. [1 alpha-hydroxycholecalciferol treatment of a 2-year-old child with severe renal osteodystrophy].
Hansen HE; Christensen MS; Nielsen HE; Johannsen A
Ugeskr Laeger; 1978 Apr; 140(16):919-21. PubMed ID: 653843
[No Abstract] [Full Text] [Related]
24. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
Massry SG; Goldstein DA; Malluche HH
Kidney Int; 1980 Oct; 18(4):409-18. PubMed ID: 7014981
[No Abstract] [Full Text] [Related]
25. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
[TBL] [Abstract][Full Text] [Related]
26. Thoracic Deformity and Acro-Osteolysis in Severe Renal Osteodystrophy.
Govindu R; Ammar H
Mayo Clin Proc; 2019 Nov; 94(11):2358-2359. PubMed ID: 31685157
[No Abstract] [Full Text] [Related]
27. Evolution of bone disease over 10 years in 135 patients with terminal renal failure.
Tatler GL; Baillod RA; Varghese Z; Young WB; Farrow S; Wills MR; Moorhead JF
Br Med J; 1973 Nov; 4(5888):315-9. PubMed ID: 4758422
[TBL] [Abstract][Full Text] [Related]
28. [Progression of hyperparathyroidism during hemodialysis. Response to conservative treatment].
García de Vinuesa S; Luño J; González C; Resano M; Allés A; Olivas E; Barril G; Valderrábano F
Rev Clin Esp; 1982 Feb; 164(3):163-7. PubMed ID: 6896386
[No Abstract] [Full Text] [Related]
29. Bone disease and chronic renal failure.
Bourke E
Ir J Med Sci; 1974 Jul; 0(0):suppl:72-4. PubMed ID: 4604173
[No Abstract] [Full Text] [Related]
30. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
Voigts AL; Felsenfeld AJ; Llach F
Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
[TBL] [Abstract][Full Text] [Related]
31. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
Pierides AM; Ellis HA; Simpson W; Cook D; Kerr DN
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409
[TBL] [Abstract][Full Text] [Related]
32. Treatment of renal bone disease.
Lancet; 1979 Dec 22-29; 2(8156-8157):1339-40. PubMed ID: 92678
[No Abstract] [Full Text] [Related]
33. [Radiologic study of renal osteodystrophy].
Bilbao JI; Villaró J; San Julián M; Purroy A
Rev Med Univ Navarra; 1982 Dec; 26(4):229-37. PubMed ID: 7182894
[No Abstract] [Full Text] [Related]
34. Effectiveness of 1 alpha-hydroxyvitamin D3 in children with renal osteodystrophy associated with hemodialysis.
Chan JC; Oldham SB; DeLuca HF
J Pediatr; 1977 May; 90(5):820-4. PubMed ID: 853343
[TBL] [Abstract][Full Text] [Related]
35. Renal osteodystrophy in patients on chronic haemodialysis. A radiological study.
Cohen ME; Cohen GF; Ahad V; Kaye M
Clin Radiol; 1970 Apr; 21(2):124-34. PubMed ID: 5420264
[No Abstract] [Full Text] [Related]
36. [Bone metabolism markers and bone histomorphometry in children with chronic renal failure in predialysis period during growth hormone treatment].
Pańczyk-Tomaszewska M; Ziółkowska H; Debiński A; Sawicki A; Zurowska A; Pietrzyk JA; Roszkowska-Blaim M
Pol Merkur Lekarski; 2000 Apr; 8(46):264-5. PubMed ID: 10897642
[TBL] [Abstract][Full Text] [Related]
37. Calcium metabolism in renal failure.
David DS
Am J Med; 1975 Jan; 58(1):48-56. PubMed ID: 1090150
[TBL] [Abstract][Full Text] [Related]
38. Renal osteodystrophy. Effect of hemodialysis and 1 alpha-hydroxy vitamin D3 on bone lesions and metacarpal bone mass.
Andresen J; Nielsen HE; Johannsen A
Acta Radiol Diagn (Stockh); 1980; 21(4):541-4. PubMed ID: 7457184
[TBL] [Abstract][Full Text] [Related]
39. Cessation of bone loss in chronic renal failure by 1-alpha-hydroxyvitamin D3: a controlled trial.
Madsen S; Olgaard K; Ladefoged J
Proc Eur Dial Transplant Assoc; 1978; 15():517-23. PubMed ID: 311003
[TBL] [Abstract][Full Text] [Related]
40. [Bone changes induced by hormones in renal osteopathy. Studies on the macro- and microstructure of bones].
von Babo H; Heuck F
Radiologe; 1974 May; 14(5):225-31. PubMed ID: 4603368
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
